← Open Payments lookup

MICHELE BUSTARD: Open Payments

NPI 1720591902 · MULLICA HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$463 in 24 payments from 13 companies in 2025. Trend: 2023 $309 · 2024 $368 · 2025 $463

Food & beverage: $463
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.4$94
Fresenius USA Marketing, Inc.4$88
Boehringer Ingelheim Pharmaceuticals, Inc.3$49
SCPHARMACEUTICALS INC.2$40
Calliditas Therapeutics US Inc.2$32
Vifor Pharma, Inc.2$30
Daiichi Sankyo Inc.1$22
Novartis Pharmaceuticals Corporation1$21
Lilly USA, LLC1$21
Apellis Pharmaceuticals, Inc.1$20

Products named: Kerendia, VELPHORO, JARDIANCE, FUROSCIX, TARPEYO, Veltassa, INJECTAFER, Fabhalta.

Industry payments across NJ — which companies pay providers there.